Emergent BioSolutions Cash Flow Statement (2010-2026) | EBS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	4.60M	-32.70M	177.90M	-3.70M	-56.40M	-87.10M	-67.00M	-186.20M	-261.40M	-263.40M	-49.50M	9.00M	-283.10M	114.80M	-31.30M	68.00M	-12.00M	51.20M	-54.60M	6.80M
Depreciation and Depletion (Quarter)	18.50M	14.40M	15.70M	16.60M	28.50M	20.30M	18.00M	17.60M	16.80M	11.70M	13.40M	11.70M	12.20M	10.10M	9.70M	9.10M	7.30M	7.10M	7.20M	7.00M
Share-based Compensation (Quarter)	11.40M	10.40M	10.10M	9.90M	12.30M	11.20M	11.70M	6.80M	8.30M	4.00M	4.00M	5.90M	5.50M	2.30M	4.30M	1.50M	4.60M	4.80M	5.30M	1.90M
Deferred Taxes (Quarter)	-1.50M	3.80M	45.40M	1.90M	0.70M	22.90M	-54.10M	-4.70M	-1.70M	2.70M	-5.20M	-12.20M	-0.20M	7.30M	-0.40M	18.60M	-13.90M	-10.20M	1.50M	-4.50M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	0.60M	0.90M	-6.10M	5.00M	1.30M	0.60M	0.20M	-0.30M	0.40M	-1.10M	0.10M	3.10M	0.10M		0.50M	11.30M			0.40M	3.90M
Asset Writedowns and Impairment (Quarter)									306.70M				27.20M						12.20M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-29.70M	16.70M	328.10M	-37.30M	-15.60M	-74.00M	92.80M	-184.00M	-114.40M	60.00M	32.10M	-62.60M	47.50M	153.70M	-79.90M	-11.20M	106.40M	-2.30M	77.70M	-33.80M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)							6.70M			218.20M
Amortization of Deferred Charges (Quarter)	1.00M	1.10M	1.00M	1.00M	1.00M	1.10M	1.00M	1.00M	8.90M	5.70M	5.70M	6.90M	5.00M	-6.70M	2.20M	2.30M	2.40M	2.50M	2.60M	1.80M
Depreciation & Amortization (CF) (Quarter)	33.20M	32.70M	29.20M	30.90M	44.50M	32.20M	35.70M	34.60M	32.90M	28.00M	29.60M	27.90M	28.50M	26.40M	26.00M	25.40M	23.50M	23.40M	23.50M	23.50M
Change in Working Capital
Change in Receivables (Quarter)	76.80M	80.00M	-98.50M	-93.70M	-4.00M	15.20M	-35.60M	-2.60M	132.40M	-71.30M	-36.90M	50.00M	-20.40M	-82.30M	77.10M	73.30M	-118.50M	71.60M	-51.90M	38.90M
Change in Inventory (Quarter)	-20.20M	-21.70M	8.60M	50.10M	25.40M	27.30M	-127.70M	30.70M	-5.80M	0.10M	-25.60M	4.50M	13.00M	18.00M	-11.00M	2.20M	24.70M	17.60M	-14.20M	-15.80M
Change in Account Payables (Quarter)	-12.10M	-4.50M	-5.10M	-14.70M	7.10M	-4.20M	-2.20M	31.00M	-20.10M	6.80M	-7.10M	-2.40M	2.60M	-23.00M	-10.20M	-5.40M	-10.40M	-4.00M	11.40M	-14.40M
Change in Accured Expenses (Quarter)	8.00M	10.30M	15.10M	-32.20M	18.10M	8.40M	-61.00M	-14.70M	0.90M	13.00M	-54.90M	-33.30M	37.10M	-13.70M	22.20M	-32.20M	5.90M	-0.70M	9.70M	-20.20M
Change in Taxes (Quarter)				-5.50M	-40.90M	-4.60M	79.70M	12.90M	1.30M	-17.70M	-12.70M	16.10M	0.00	10.50M	-3.30M	-8.40M	6.80M	6.20M	-6.30M	4.60M
Other Working Capital Changes (Quarter)	-9.60M	400.00M	-62.50M	-2.00M	4.70M	1.50M	-25.00M	4.50M	13.30M	0.50M	-12.40M	-19.70M	0.20M	0.70M	-1.50M	-9.50M	9.40M	1.20M	-12.80M	3.20M
Investing Activities
Capital Expenditures (Quarter)	90.60M	55.20M	45.80M	13.30M	51.00M	27.90M	-82.80M	7.80M	-0.10M	1.50M	42.40M	10.80M	4.60M	-13.80M	0.30M	1.50M	0.70M	7.70M	-8.30M	2.40M
Sales of Property, Plant and Equipment (Quarter)														7.60M	0.30M	38.10M	0.10M
Acquisitions (Quarter)
Divestments (Quarter)									74.90M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)	-67.00M	-55.20M	-45.80M	-32.20M	-32.10M	-271.60M	-45.40M	-15.10M	257.70M	-18.90M	-11.40M	-10.80M	-4.60M	112.00M	28.60M	59.50M	17.20M	-3.40M	-3.90M	-2.40M
Financing Activities
Other financing activities (Quarter)														8.70M
Cash from Financing Activities (Quarter)	-3.80M	-5.00M	-110.00M	-70.50M	-30.70M	229.30M	353.10M	-10.50M	-486.90M	-43.00M	4.70M	40.70M	-50.90M	-180.30M	0.50M	-0.40M	-6.40M	-15.90M	-113.90M	-11.40M
Additional items
Exchange Rate Effect (Quarter)	0.20M	-0.20M		-0.30M	0.70M	-1.00M	1.10M	-0.20M	-0.60M	1.10M	-1.50M					-0.70M	1.00M	-0.20M
Change in Cash (Quarter)	-100.30M	-43.70M	172.30M	-140.30M	-77.70M	-117.30M	401.60M	-209.80M	-344.20M	-0.80M	23.90M	-32.70M	-8.00M	85.40M	-50.80M	47.20M	118.20M	-21.80M	-40.10M	-47.60M
Free Cash Flow (Quarter)	-120.30M	-38.50M	282.30M	-50.60M	-66.60M	-101.90M	175.60M	-191.80M	-114.30M	58.50M	-10.30M	-73.40M	42.90M	167.50M	-80.20M	-12.70M	105.70M	-10.00M	86.00M	-36.20M
Net Cash Flow (Quarter)	-100.50M	-43.50M	172.30M	-140.00M	-78.40M	-116.30M	400.50M	-209.60M	-343.60M	-1.90M	25.40M	-32.70M	-8.00M	85.40M	-50.80M	47.90M	117.20M	-21.60M	-40.10M	-47.60M

Research Tools

Emergent BioSolutions Cash Flow Statement (2010-2026) | EBS

Create an account

Sign In

Reset Password